Credit Suisse Ag Benitec Biopharma Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$2.59 - $9.26 $40,347 - $144,252
-15,578 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$5.66 - $8.7 $88,171 - $135,528
15,578 New
15,578 $98,000

Others Institutions Holding BNTC

# of Institutions
2
Shares Held
797K
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $295M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email